| Latest | F'cast | |
|---|---|---|
| Div Yield | 0.0% | |
| Div Cover | n/a | |
| Op Mrgn | 29.8% | |
| ROCE | 55.0% |
| Latest | F'cast | |
|---|---|---|
| P/E | 23.8 | |
| PEG | 0.5 | |
| Pr/Revenue | 6.3 | |
| Pr/Book | 5.5 |
| Latest | F'cast | |
|---|---|---|
| Revenue | 33.5% | |
| PBT | 40.2% | |
| EPS | 52.1% | |
| DPS | n/a |
| Year Ending | Revenue ($m) | Pre-tax ($m) | EPS | P/E | PEG | EPS Grth. | Div | Yield |
|---|---|---|---|---|---|---|---|---|
| 31-Dec-07 | 1,405.82 | 516.97 | 59.00¢ | 78.3 | 0.4 | +195% | n/a | 0.0% |
| 31-Dec-08 | 2,254.78 | (1,368.82) | (346.00)¢ | n/a | n/a | n/a | n/a | 0.0% |
| 31-Dec-09 | 2,689.89 | 975.70 | 169.00¢ | 32.9 | n/a | n/a | n/a | 0.0% |
| 31-Dec-10 | 3,625.75 | 1,012.61 | 190.00¢ | 31.1 | 2.6 | +12% | n/a | 0.0% |
| 31-Dec-11 | 4,842.07 | 1,419.52 | 289.00¢ | 23.4 | 0.4 | +52% | n/a | 0.0% |
| Year Ending | Revenue ($m) | Pre-tax ($m) | EPS | P/E | PEG | EPS Grth. | Div | Yield |
|---|---|---|---|---|---|---|---|---|
| 31-Dec-12 | 5,456.68 | 2,565.15 | 478.96¢ | 14.4 | 0.2 | +66% | n/a | 0.0% |
| 31-Dec-13 | 6,144.12 | 2,968.47 | 567.07¢ | 12.2 | 0.7 | +18% | n/a | 0.0% |
Copyright © 2012 FactSet Research Systems Inc. All rights reserved.
| US broker round-up | 10-Jan-2012 | ShareCast |
| For Biotech, a Tax Break Spells Hope | 10-Dec-2008 | New York Times |
| Celgene to buy Pharmion | 19-Nov-2007 | LA Times |
| Celgene to Acquire Pharmion | 19-Nov-2007 | New York Times |
| Currency | US Dollars |
| Share Price | $ 68.90 |
| Change Today | $ -1.01 |
| % Change | -1.44 % |
| 52 Week High | $80.29 |
| 52 Week Low | $51.85 |
| Volume | 2,611,439 |
| Shares Issued | 440.50m |
| Market Cap | $30,350m |
| Beta | 0.68 |
| RiskGrade | 108 |
| Strong Buy | 21 |
| Buy | 2 |
| Neutral | 7 |
| Sell | 0 |
| Strong Sell | 0 |
| Total | 30 |

| Time | Volume / Share Price |
| 16:00 | 583 @ $68.90 |
| 16:00 | 182 @ $68.90 |
| 16:00 | 1,698 @ $68.90 |
| 16:00 | 1,152 @ $68.90 |
| 16:00 | 166 @ $68.90 |
You are here: research